Patients & Caregivers
Josh Brolin Is Having Fun Helping the Rare Disease Community
Proceeds from the sales will go to St. Jude Children's Research Hospital and the Epidermolysis Bullosa Medical Research Foundation.
McCain Back at Work 10 Days after Brain Surgery
Just 10 days after undergoing surgery to remove a tumor in his brain, Arizona Senator John McCain is back at work in Washington D.C.
Government Begins Study to Test Targeted Therapies in Childhood Cancer
Pediatric MATCH is enrolling children and adolescents with solid tumors who have progressed either during or after standard therapy.
Senator John McCain Has Brain Cancer
Glioblastoma is the same type of cancer that the late Senator Ted Kennedy had.
Blincyto Gets FDA Full Approval to Treat ALL in Adults and Children
Adults with relapsed or refractory ALL generally have a poor prognosis with a median survival time of 3 to 5 months.
Napoleon and Hereditary Cancer
The emperor often talked about cancer and prior to his death, he demanded an autopsy be performed and his stomach be examined.
FDA Puts Clinical Hold on Merck's Multiple Myeloma Trials Following Increased Deaths
The review panel found more deaths in multiple myeloma patients getting pembrolizumab plus pomalidomide or lenalidomide vs control groups.
TV Personality Maria Menounos Had Rare Brain Tumor
Menounos began to suspect she had brain cancer based on her own symptoms (trouble speaking) as well as her experience caring for her mother who currently has stage 4 brain cancer.
FDA Approves Expanded Use of Cooling Cap for All Solid Tumor Patients
Alopecia, or hair loss, is a common side effect of chemotherapies often used to treat treatment solid tumor cancers.
FDA Approves Diagnostic Test for Rare Blood Cancers
The FDA has approved Beckman Coulter's ClearLLab Reagents to help diagnose numerous rare blood cancers, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).
<< Prev Page
Next Page >>
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.